This article provides a comprehensive guide to risk assessment for manufacturing process changes, specifically tailored for researchers, scientists, and drug development professionals in the pharmaceutical and biotech industries.
This article provides a comprehensive guide to demonstrating comparability for biotechnological/biological products following manufacturing process changes, as outlined in ICH Q5E and related regulatory guidances.
This article provides drug development researchers and scientists with a comprehensive analysis of the paradigm shift in regulatory expectations for product comparability.
This article provides a comprehensive overview of the critical role post-translational modifications (PTMs) play in demonstrating product comparability during biopharmaceutical development.
This article provides drug development researchers and scientists with a comprehensive framework for understanding and implementing Critical Quality Attribute (CQA) assessments in comparability studies.
This article provides a critical analysis of common cell detachment methods, including enzymatic, non-enzymatic, and novel electrochemical techniques, for researchers and drug development professionals.
This article synthesizes current evidence on the profound impact cell detachment techniques have on subsequent metabolomic analysis.
This article provides a comprehensive guide for researchers and drug development professionals on assessing cell health following various detachment methods.
This article synthesizes current evidence demonstrating that Accutase, a commonly used enzymatic cell detachment solution, significantly cleaves and reduces the cell surface expression of the Fas receptor (CD95) and its...
Accurate sample preparation is the cornerstone of reliable cell metabolomics, and the choice between mechanical scraping and enzymatic detachment is a critical, yet often overlooked, step.